Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria
B Gao, RS Gupta - Microbiology and molecular biology reviews, 2012 - Am Soc Microbiol
The phylum Actinobacteria harbors many important human pathogens and also provides
one of the richest sources of natural products, including numerous antibiotics and other …
one of the richest sources of natural products, including numerous antibiotics and other …
Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and other mycobacteria
T Jagielski, A Minias, J van Ingen… - Clinical microbiology …, 2016 - Am Soc Microbiol
Molecular typing has revolutionized epidemiological studies of infectious diseases,
including those of a mycobacterial etiology. With the advent of fingerprinting techniques …
including those of a mycobacterial etiology. With the advent of fingerprinting techniques …
CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
JW Ai, X Zhou, T Xu, M Yang, Y Chen… - Emerging microbes & …, 2019 - Taylor & Francis
Rapid and simple-to-use diagnostic methods for tuberculosis are urgently needed. Recent
development has unveiled the diagnostic power of the CRISPR system in the detection of …
development has unveiled the diagnostic power of the CRISPR system in the detection of …
TubercuList–10 years after
JM Lew, A Kapopoulou, LM Jones, ST Cole - Tuberculosis, 2011 - Elsevier
TubercuList (http://tuberculist. epfl. ch/), the relational database that presents genome-
derived information about H37Rv, the paradigm strain of Mycobacterium tuberculosis, has …
derived information about H37Rv, the paradigm strain of Mycobacterium tuberculosis, has …
[HTML][HTML] Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis
Mycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients
with active tuberculosis elicit protective antibodies, and against which antigens, is still …
with active tuberculosis elicit protective antibodies, and against which antigens, is still …
Microevolution of extensively drug-resistant tuberculosis in Russia
N Casali, V Nikolayevskyy, Y Balabanova… - Genome …, 2012 - genome.cshlp.org
Extensively drug-resistant (XDR) tuberculosis (TB), which is resistant to both first-and
second-line antibiotics, is an escalating problem, particularly in the Russian Federation …
second-line antibiotics, is an escalating problem, particularly in the Russian Federation …
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Pyrazinamide (PZA) is a frontline anti-tuberculosis drug that plays a crucial role in the
treatment of both drug susceptible and multidrug-resistant tuberculosis (MDR-TB) …
treatment of both drug susceptible and multidrug-resistant tuberculosis (MDR-TB) …
Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories
TR Ioerger, Y Feng, K Ganesula, X Chen… - Journal of …, 2010 - Am Soc Microbiol
The publication of the complete genome sequence for Mycobacterium tuberculosis H37Rv
in 1998 has had a great impact on the research community. Nonetheless, it is suspected that …
in 1998 has had a great impact on the research community. Nonetheless, it is suspected that …
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
Pyrazinamide (PZA) is a frontline anti-tuberculosis drug that plays a crucial role in the
treatment of both drug-susceptible and multidrug-resistant tuberculosis (MDR-TB). PZA is a …
treatment of both drug-susceptible and multidrug-resistant tuberculosis (MDR-TB). PZA is a …
Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis
Objectives Although clofazimine has been traditionally used to treat leprosy, there is recent
interest in using clofazimine for the treatment of MDR-TB and drug-susceptible TB. However …
interest in using clofazimine for the treatment of MDR-TB and drug-susceptible TB. However …